Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ACEA Biosciences Announces New Patent

Published: Thursday, February 17, 2011
Last Updated: Thursday, February 17, 2011
Bookmark and Share
Broad claims granted for cytotoxicity profiling and chemical compound testing on the xCELLigence system.

ACEA Biosciences, Inc., a pioneer in the development of high-performance microelectronic systems for cell-based assays, diagnostics, and pharmaceutical research, has reported the issuance of a new U. S. Patent for chemical compound screening, with important applications in the development of new pharmaceutical products.

Testing and profiling of these candidate compounds by means of ACEA's real-time, label-free microelectronic technology provides the user with an accurate and cost effective method of screening chemical compounds and cytotoxicity profiling.

The xCELLigence System, invented by ACEA Biosciences and further co-developed by ACEA Biosciences and its cooperation partner Roche Applied Science, is marketed on a worldwide basis with Roche Applied Science.

As stated by Dr. Yama Abassi, ACEA's Senior Director of Research and Development, and Lead Inventor of the new patent: “The xCELLigence System is broadly used in biomedical research, toxicology, and pharmaceutical development. The new patent broadly covers the use of our real-time, label-free technology in the important area of drug discovery and pharmaceutical research and allows the investigator to effectively screen chemical compounds for cytotoxicity, and changes in cell behavior attributed to the chemical compound being tested. Importantly, what distinguishes this approach compared to traditional cytotoxicity assays is that it has the potential to reveal mechanism of toxicity which has implication in both pharmaceutical drug discovery and preclinical safety.”

The new patent (US Patent No. 7,876,108, issued on January 25, 2011) entitled "Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays“ includes broad claims for screening chemical compounds and chemical compositions for cytotoxic activities, and is very useful in testing the effects of compounds on growing cells, greatly simplifying the complicated process of chemical compound screening.

"We are very pleased to see this important addition to our patent portfolio," said Dr. Xiaobo Wang, ACEA Bioscience's Chief Technology Officer. "Chemical compound screening and cytotoxicity are very important and critical components in the drug discovery process, and the new patent, which is specifically related to the use of our label-free, real-time microelectronic technology in drug discovery, evaluates the novel label-free technology that makes this possible. The new patent clearly shows the usefulness of our impedance-based microelectronic technology in drug discovery and pharmaceutical research."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!